Probing Cortical Sites of Antipsychotic Drug Action within vivoReceptor Imaging
Open Access
- 1 January 2000
- journal article
- research article
- Published by Hindawi Limited in Behavioural Neurology
- Vol. 12 (1-2) , 3-9
Abstract
Imaging receptors using radioactive ligands has allowed direct determination of the sites of action of antipsychotic drugs. Initial studies relating antipsychotic drug efficacy to action at striatal dopamine D2-like receptors have recently been undermined. Developments in imaging extrastriatal dopamine D2-like receptors suggest rather that antagonism of these receptors in the temporal cortex is the common site of action for antipsychotic drugs, with occupancy at striatal receptors relating more closely to extrapyramidal side effects. Further work into dopamine receptor subtypes and other receptor groups such as serotonin and GABA neurotransmitters awaits the development of suitable probes, but there are some initial finding. Again a main site of antipsychotic drug action is at cortical levels with high degrees of cortical D1 and 5HT2a receptor occupancy attained particularly by atypical antipsychotic drugs.Keywords
This publication has 24 references indexed in Scilit:
- IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidolPsychopharmacology, 1997
- Phencyclidine (PCP) acts at σ sites to induce c-fos gene expressionBrain Research, 1997
- Nuclear medicine in clinical diagnosis and treatment, volumes 1 and 2Emergency Radiology, 1996
- Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor bindingPsychopharmacology, 1996
- Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptorsEuropean Journal of Pharmacology, 1994
- Visualization of extrastriatal dopamine D2 receptors in the human brainEuropean Journal of Pharmacology, 1992
- Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.The Journal of Pharmacology and Experimental Therapeutics, 1992
- D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neurolepticsPsychopharmacology, 1989
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988
- Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat.The Journal of Pharmacology and Experimental Therapeutics, 1982